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Abstract
Background An increasing array of rare inherited conditions can be
detected as part of the universal newborn screening programme. The
introduction and evaluation of these service developments require
consideration of the ethical issues involved and appropriate mech-
anisms for informing parents and gaining consent if required.
Exploration of parental views is needed to inform the debate and
speciﬁcally consider whether more ﬂexible protocols are needed to ﬁt
with the public perception of new developments in this context.
Objective This study has been undertaken to explore perceptions
and attitudes of parents and future parents to an expanded newborn
screening programme in the United Kingdom and the necessary
information provision and consent processes.
Design and participants A mixed methods study involving focus
groups (n = 29) and a web-survey (n = 142) undertaken with
parents and future parents.
Results and conclusions Parents want guaranteed information
provision with clear decision-making powers and an awareness of
the choices available to them. The diﬀerence between existing
screening provision and expanded screening was not considered to
be signiﬁcant enough by participants to warrant formal written,
informed consent for expanded screening. It is argued that the
ethical review processes need to be more ﬂexible towards the
provision of information and consent processes for service develop-
ments in newborn screening.
Introduction
In the United Kingdom, newborn screening is
routinely oﬀered for a number of conditions
through testing of a heel-prick blood spot taken
in the ﬁrst week after birth.1 As a result of
technological development and speciﬁcally the
potential of tandem mass spectrometry,2 rapid
detection of a much larger number of inherited
metabolic diseases is possible early in a childs
life. This approach has now become widely
adopted in many developed countries, and the
eﬀectiveness of these programmes is currently
under evaluation. All states in the USA now
screen for 53 core conditions as part of their
Federal programme, and many countries within
the EU screen for between 2 and 19 such dis-
orders.
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In the United Kingdom, before screening for a
condition is adopted by the national screening
programme, the proposal is properly subject to a
comprehensive assessment of the likely beneﬁts,
harms and costs of screening.1,3 Currently, a
proposal is being considered to include ﬁve addi-
tional inherited disorders, with a collective inci-
dence of approximately 1:30 000 live births; they
include the following: glutaric aciduria type 1,4
isovaleric acidaemia,5 non-pyridoxine responsive
homocystinuria,6 maple syrup urine disease7 and
long-chain hydroxyl acyl CoA dehydrogenase
deﬁciency.8 Whilst of enormous beneﬁt to the
children detected, such developments undertaken
to evaluate the expansion of screening delivered,
require consideration of not only the clinical and
ﬁnancial issues involved, but also the ethical issues
for the whole population.
Screening, whether as part of service provision
or research, requires participant consent pro-
cesses.9,10 For current newborn screening pro-
vision in the United Kingdom, this is through a
process of informed choice or dissent, whereby
a parent is expected to make a rational and
informed choice regarding their childs health,
and is entitled to opt-out of the national
screening programme.9 It is important for any
service developments that similar safeguards are
in place and that parents receive an appropriate
level of information to enable an informed
choice on behalf of their child. Here, the model
of consent for an expanded screening pro-
gramme in the United Kingdom is considered.
UK research suggests that voluntary informed
choice may not always be obtained for newborn
screening under service provision.11 Screening is
often experienced as a routine test, where parents
are not even aware that they have a clear choice to
make.12 An expanded programme, where the
range of screened conditions is extended to very
rare conditions, raises questions regarding the
amount and type of information parents need to
consider consenting to their childs inclusion.
Gaining consent is challenging where there may
be conﬂict between parental choice, eﬃcient ser-
vice provision and health promotion.13 Fully
informed written consent for expanded screening
presents challenges,14,15 which may impede
development, burden health professionals and
could reduce participation in the core screening
programme.11,14 It may limit sample sizes and
create barriers to techniques that are safe
and provide health beneﬁts, whilst adding cost
and logistical complexity.13 Given the rarity and
complexity of the conditions for which screening
is possible, as well as the complexity of the
screening process, educating parents to meet the
criteria for fully informed consent is likely to be
very diﬃcult.16–18
There is an assumption that by providing the
right information to parents, they will make an
informed choice. However, this ignores indi-
vidual diﬀerences in decision making and
the impact of social and cultural factors that
inﬂuence whether information can be translated
into eﬀective decision making at the individual
level.19 Decision-making ability can be com-
promised by anxiety, dependence on and trust in
the medical system and the challenge of new
parenthood, as well as parents ability to read
and retain information.20 Further issues of
information overload, parental anxiety, existing
psychological commitment to the test and
providing insuﬃcient information, are all valid
concerns.16,21
Whilst parental understanding and reassur-
ance is paramount, Helgesson et al.22 argue that
legal regulations and ethical guidelines often
suggest quite advanced understanding of infor-
mation is necessary for informed consent. They
counter that a basic understanding should ethi-
cally be suﬃcient: that it is up to the parent to
decide, that they have an unrestricted right to
withdraw consent at any time and realize the
expected beneﬁts and costs (in terms of risks and
time).23,24
Documenting informed consent through
consent forms and signatures does not ensure
informed decision making.22 Tarini et al.25
argue the focus should be on eﬀective commu-
nication and education about screening rather
than gaining written individual consent,
although the opportunity to opt-out should
always be available. Whilst ethicists suggest that
opt-out strategies can reduce participant auton-
omy, opt-in recruitment strategies have been
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shown to result in lower response rates and a
biased sample.26 Studies exploring patient and
maternal satisfaction have shown equal satis-
faction whether an opt-in or opt-out procedure
is employed.27 Written consent has been shown
to be less important to the participants when the
development was considered a continuation of
an already initiated clinical service (such as
screening).14 However, it is noteworthy that in
Germany, an expanded newborn screening
programme employing written parental consent
still demonstrated high compliance.28
Within the context of UK expanded newborn
screening, it is argued that exploration of
parental views on consent practices is needed to
further inform the debate and consider whether
more ﬂexible procedures are needed to ﬁt with
the public perception of the expansion and the
opportunity to develop the service. To date, this
has received little consideration.13 Parental
views and preferences have been analysed in
respect to routine screening provision.29–32
These studies have demonstrated that parents
have limited knowledge about newborn screen-
ing practices and often are not aware of having
provided explicit consent. The need for clear,
brief and accurate patient information that takes
into account parents needs has been high-
lighted.12,13 Detmar et al. speciﬁcally considered
views on the expansion of the neonatal screening
programme in the Netherlands.31,32 The medical
beneﬁts of screening were recognized, and
almost 100% of their sample would participate.
The parents held mixed views on whether
informed consent was necessary. Here, a study
of the views of UK parents and parents-to-be
are considered in respect to the expansion of
newborn screening, information provision and
consent practices.
Methods
A combined methodology was employed
involving focus groups and an online survey run
in parallel. Ethical approval was sought and
granted by the Coventry University Ethics
Committee.
Online survey
The anonymous web-based survey enabled eﬃ-
cient collection and analysis of data from a
larger, dispersed sample. It oﬀered the advan-
tages of minimizing social desirability and
interview bias, whilst allowing quantiﬁcation of
results.
Sampling
The survey was widely and publicly accessible on
the internet, although it was expected that the
majority of respondents would be parents or
expectant parents. A free prize draw of £100 of
shopping vouchers was used to encourage par-
ticipation. The survey link was distributed
through various mailing lists (e.g. the local
council, local Childrens Centres) as well as
postings on parental support groups. Distribu-
tion was particularly aimed at gaining the views
of parents of children aﬀected by inherited
conditions, and a number of organizations (e.g.
Cystic Fibrosis Trust, CLIMB and Genetic
Interest Group) circulated the survey link and
advertised the project on their websites. A rela-
tively small motivated sample was expected
owing to the subject matter and length of the
survey.
The survey was fully completed by 142 par-
ticipants (see Table 1) for gender and parental
status summary). A further 45 participants
submitted incomplete surveys; these were
removed from the analysis.
Table 1 Characteristics of survey participants
Survey
sample
Focus
group
sample
Gender
Male 16 2
Female 124 27
Parental status
Parents of healthy child 108 24
Parents-to-be 6 5
Parents of child with disorder 13 0
None of the above 15 0
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Data collection and analysis
The survey was run using SurveyMonkey.com
software.33 Following a brief demographics
section (10 questions), the survey consisted of 36
questions for all participants. The majority of
the questions were multiple choice, with nine
open questions asking for more detailed
responses. Completion took approximately
30 min.
The questions addressed participants expe-
riences of screening, the information given and
the mechanism by which consent was obtained.
Expanded newborn screening was explained as
well as the diﬀerence between routine screening
as part of existing service provision and the
expanded newborn screening programme. A
potential participant information sheet for
expanded newborn screening was embedded
within the survey. The leaﬂet, developed with
metabolic condition specialists, was an adapted
version of the Newborn blood spot screening
for your baby leaﬂet produced by the UK
Newborn Screening Programme Centre.34 The
main addition to the leaﬂet was a section
speciﬁcally referring to inherited metabolic
diseases which could potentially be the focus
of an expanded screening programme. The
participants were asked to read the informa-
tion as if they were deciding whether they
would like their child to take part and then
asked a series of questions. Questions were
also posed about willingness to take part in
the programme and appropriate means of
providing consent.
As this was an exploratory survey investigat-
ing experience, attitudes and perceptions,
descriptive statistics rather than tests of statisti-
cal inference were undertaken.
Focus groups
The focus groups allowed more in-depth dis-
cussion of issues with harder to reach popula-
tions, who may have been less likely to access an
online survey.
Participants
Participants were recruited through local chil-
drens centres and antenatal groups. Four focus
groups and three interviews were undertaken
with 29 participants in total. This included
individuals with children who had experienced
newborn screening, as well as future parents.
Participants were provided with refreshments
and a £10 shopping voucher for attending the
session.
The aim was to engage groups with poten-
tially diﬀerent viewpoints and experiences,
although each focus group comprised of parti-
cipants with similar socio-economic back-
grounds to encourage group dynamics. As
illustrated in Table 2, this included new parents
who had recently experienced newborn screening
(within the previous 10 weeks); parents who had
experienced screening within the last 2 years;
and mothers of a South Asian origin (children
all under 2 years). One of two groups run with
South Asian mothers was conducted in Urdu
Table 2 Focus group participants
Number of
participants Ethnic origin Age of children Recruited through
Focus group 1 10 White British Under 2 years Local childrens centre
Focus group 2 5 South Asian
(ﬂuent English speakers)
Under 2 years Local childrens centre
Focus group 3 3 South Asian
(non-English speakers)
Under 2 years Local childrens centre
Focus group 4 6 Mixed ethnic origin Under 10 weeks National Childbirth Trust
Interviews 5 White British Expectant parents
in the ﬁnal trimester
of pregnancy
National Childbirth Trust
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and translated into English. Owing to diﬃculties
experienced in getting expectant parents toge-
ther for a focus group, three interviews were
undertaken with expectant parents in the ﬁnal
trimester: two were run with couples and one on
a one-to-one basis.
Data collection and analysis
Each focus group and interview lasted between
30 and 90 min. The discussions were directed
using a standard schedule and material for dis-
cussion. Whilst the approach oﬀered some
structure, it was possible to discuss issues as they
were raised by participants. Discussion topics
included participants experiences of screening,
the information given and the mechanisms by
which consent was obtained. Expanded newborn
screening was explained to the participants. The
newborn screening leaﬂet as described above
was presented for discussion. Participants were
asked to read and review the information pro-
vided in terms of its content, readability and
suitability. The concepts of informed dissent and
consent were then explained and their appro-
priateness to the proposed programme dis-
cussed.
The discussions were recorded and tran-
scribed. Transcripts were analysed as separate
groups by a researcher and the data subjected to
thematic analysis in accordance with Braun and
Clarke.35 An inductive approach was used to
identify predominant themes across the data and
provide conﬁdence that the emerging ﬁndings
were not obscured by existing evidence and
theory. Accordingly, the researcher was unfa-
miliar with literature on screening and informed
consent at the time of data collection and anal-
ysis. Following line-by-line coding, themes were
identiﬁed at the semantic level, that is, the ana-
lytical focus was on explicit surface meanings of
the data and not on looking for anything beyond
what the respondents said. Transcripts were
coded to identify relevant aspects of the data,
once a comprehensive set of codes had been
identiﬁed; repeated patterns across the data set
were identiﬁed to generate themes. These themes
were then reviewed and reﬁned and illustrative
quotations selected.
Results
Experiences of routine screening
Twenty-four of twenty nine focus group partic-
ipants and 92.6% of surveyed parents (79% of
total sample) had children who had been
screened in the United Kingdom. Most of the
parents had little recollection of speciﬁcally what
the testing had been for. The experiences
recalled by focus group parents included
whether their partner had been present (which
was often not the case) and whether the heel-
prick caused any distress. A feeling of distress as
the blood was taken was not uncommon:
yeah, I cried my eyes out (P7 L11)
Twenty-one percent of parents completing the
survey agreed that they were anxious about the
safety of their child during the heel-prick. Mid-
wife advice appeared to determine how prepared
the mother was.
Discontentment amongst focus group partici-
pants concerned the provision of screening
results. Experiences were inconsistent, with some
receiving results by letter, often later than
expected, and some assuming a negative result
having not had any contact. In two of the focus
groups, all participants reported no notiﬁcation
of results:
..they said they would send the results to the doctor
but when I asked the doctor they said no we
havent got that, and we have not got it written in
our book as well (P5, A96-97)
All parents agreed that they would have liked
prompt and formal receipt of results for reas-
surance.
Of the survey sample, 61.2% remembered
being given information about screening before
the blood spot was taken; 19.8% claimed not to
have received any. It is hard to determine
whether information was not provided, or sim-
ply not recognized or read. Discussion within
the focus groups indicated that the information
varied from none, to a leaﬂet, to a combination
of a conversation with the midwife and written
information. Many participants admitted
receiving a leaﬂet but not having read it:
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I put the leaﬂets in my bag and never read them
(P7, L239)
The verbal information provision by the
midwife was often minimal:
…with my experience I wasnt given anything, she
just came over and said we are going to do a heel-
prick test, and I said ok ﬁne (P1, A16-17)
Minimal information was not necessarily
considered a problem at the time, but on
reﬂection parents indicated that more informa-
tion or attention to the information provided
would have been useful.
Whilst subject to variation, information about
newborn screening should be provided at the 8-
week antenatal appointment, after birth and
directly before the test. Focus group and survey
participants (65%) mainly recalled information
presentation to be after birth. This was consid-
ered inappropriate:
...after you have had a kid you have got so much
on your mind that you dont want to look through
hundreds and tons of leaﬂets (P3 A121-22)
It was felt that ﬁrst time provision of infor-
mation should have been during pregnancy, with
refreshers after birth and before the test (as is
intended).
Of those survey participants who could
remember the information, 65.8% thought the
quantity was appropriate, and 62.2% indicated
that they had understood it. However, partici-
pants felt they had poor knowledge and under-
standing of which conditions were being tested
for and what they would mean for their child.
Of survey participants, 51.1% were aware that
screening is optional. When reﬂecting on their
own experiences, 41.7% reported that they did
not feel able to decline from having the blood
spot taken, with many believing screening was
compulsory:
No – thought it was compulsory, didnt realise I
had a choice and therefore a decision to make
(SQ30, P72)
Focus group participants agreed; in many
cases, screening was not presented as optional,
and an assumption was made that their child
would be screened:
..all the ones [screening tests] after birth, it is
assumed that they are just going to be done there is
no choice about it. I am going to do the heel-prick
now. It is the way it is worded (P5 S97-98)
This experience was common irrespective of
the background of participants. However, most
parents did not question the decision to have
their child screened, with 80.7% of survey par-
ticipants reporting that they had never experi-
enced doubts that the correct decision was
made.
Views on expanded newborn screening
The participants were described an expanded
newborn screening programme where the same
heel-prick blood spot taken for routine screening
would be being tested for a further ﬁve inherited
metabolic conditions.
Information requirements
Participants were asked whether an expanded
screening programme should provide diﬀerent
information to routine screening. Of survey
participants, 44.6% wanted more information
and 51.1% the same amount. An expansion of
screening could involve complex and rare con-
ditions. Participants were asked whether they
would require the same quantity of information
for rare conditions as they would for more
common and familiar conditions. There was a
diﬀerence in opinion demonstrated through
both the survey and focus group. The same
amount of information was required by 47.9%,
more by 20% and less by 26.4%. Only 2.9%
thought no information would be required.
Some felt less information was appropriate to
prevent undue concern, whilst others felt more
was needed to explain unfamiliar conditions.
Review of expanded newborn screening leaﬂet
Following review of the adapted Newborn blood
spot screening for your baby leaﬂet, survey par-
ticipants were asked to rate ease of under-
standing of the information presented, and how
well the conditions were described. The
responses were indicated on a ﬁve-point Likert
scale (strongly disagree through to strongly
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agree). The results are summarized in Fig. 1, and
it can be seen that the information was positively
regarded.
Focus group participants held diﬀering views
of the leaﬂet. Some were positive, feeling that it
contained the right level of information. Others
would have liked to be told more about the
process of the screening and the reasons for the
expansion of the programme. The leaﬂet was
criticized by two of the focus groups for being too
complicated because of the terminology used:
You see all these words…its a bit complicated (P7,
L223)
…you cant understand it just by reading the leaﬂet
(P1 U75-6)
Some criticized the leaﬂet for causing anxiety,
by stating that screened conditions could result
in death. Many felt there was too much infor-
mation presented:
I think that too much information is actually more
harmful than giving much less information (P3
S208)
Participants agreed that they would initially
like to receive basic information on screening,
with access to more detailed resources and the
capacity to individually select the additional
information that was meaningful to them. A
more detailed and lengthy leaﬂet was not
required, instead brief paper-based reading
material with the option to consult more
detailed written or web-based information, or
contact a health professional.
Participant preference for face-to-face discus-
sions with a health professional, typically the
midwife was clear. This was particularly evident
amongst the focus group participants from an
Asian background, for whom English was not
their ﬁrst language.
Timing of information provision
When asked to consider when they would want
to receive information about expanded newborn
screening in order to make a decision about their
childs inclusion, the most common response was
during late pregnancy. Other responses sug-
gested during pregnancy, as well as after giving
birth and before the tests. This is consistent with
parents reﬂections on their experiences of rou-
tine screening. Presentation late in pregnancy
would provide time and attention to be devoted
to the information and further reading if
required, before becoming overwhelmed by the
arrival of a new baby:
Yeah, probably after thirty weeks but before
38 weeks (P1 PL321)
Both the survey and focus group feedback
suggested that a reminder was needed 5–7 days
before and directly before the test. This would
allow for increased saliency of information and
changing views after the birth, and provide time
to digest additional information if required.
Decision making
The survey participants were asked whether they
could make a decision to include their child in
the programme based on the presented leaﬂet,
and 90.1% of respondents indicated that they
could. Those unable to make a decision wanted
more information, speciﬁcally about the
programme, what was being tested for and the
0% 20% 40% 60% 80% 100%
The information was easy to understand
The conditions were described well
Strongly disagree Disagree Neither agree nor disagree Agree Strongly agree
Figure 1 Review of the newborn screening leaﬂet.
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accuracy of the tests. Assuming the right amount
of information, 42.3% of survey participants felt
they would make the decision to include their
child in an expanded screening programme
straightaway; 57.7% felt they would need time
to decide. The majority would need between a
day and a week to reach a decision.
Choice and consent
Freedom of choice in expanded screening was
desired by all focus group participants:
I would like to know all the facts and make an
informed choice about what I want to do going
forward (P5 L411-12)
The risk that some parents may not act in the
best interests of their child was raised, but choice
was still important.Most parents did not consider
the option of including their child in routine
screening, yet declining from the screening of
additional conditions. Expanded screening was
seen as interlinked with routine screening, with a
broad acceptance of the proposed programme.
Potential formats for providing and recording
consent were considered. A system of opting out
of the screening programme was seen to be
desirable by 71.2% of survey participants, 27.3%
preferring opt-in and 1.4% not recognizing the
diﬀerence. Focus group discussion suggested that
a formal process involving opting-in and written
consent, if not required for routine screening,
would arouse suspicion and mistrust, causing
extra worry and making the decision harder.
I wouldnt want to sign something because it
makes it seem more formal and you have to think
more about it,……. but you always know that you
have got the chance to object (P10, L208-310)
Fully informed written consent procedures
were almost unanimously considered unneces-
sary. Choice was considered essential, but signing
for it was not.
Willingness to take part
All of the focus group participants and 92.3% of
survey participants indicated that based on the
information provided, they would be prepared
to include their child in an expanded screening
programme, and 7.7% would not be happy to
take part. The programme was perceived as low
risk as additional blood was not being taken,
and nothing was being introduced to the childs
body. Therefore, most parents and future par-
ents could only see the beneﬁts, especially of
gaining any additional knowledge about their
childs health.
Differences amongst groups
No clear diﬀerences were found in opinions
about the information provision or consent
methods for expanded screening between par-
ents and future parents, or between focus groups
based on participant background that is by area
or ethnic origin. The survey sample included a
small number of parents with children aﬀected
by conditions for which screening is currently
undertaken or possible (n = 13). In 10 of 13 of
these cases, diagnosis occurred as a result of
newborn screening. There were no clear diﬀer-
ences in the views of these parents. However,
their preferences for clear information provision
during pregnancy and their commitment to
expanded screening were evident.
Discussion
This research has examined the views of parents
and future parents, on information provision
and consent processes for expanded newborn
screening.
Experiences of routine screening
Consideration of parental experiences sought to
identify, where the current screening process
may need review if an expanded programme of
screening were to be run in parallel. In general,
the heel-prick screening test was seen as routine;
despite limited knowledge, parents were conﬁ-
dent in the potential health beneﬁts. This is
consistent with existing research in the area.12,31
It is clear that communication of expectations
and consistent follow-up in terms of results is
required. In expanded screening provision,
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preparation for any perceived negatives of the
testing process will be important to ensure
parental satisfaction with their experience.
Information provision
Whilst parents were content with the decision
made to have their child screened, knowledge
about screening, the conditions involved and
their potential impact was low. The information
given pre-screening could be improved in terms
of consistent provision, the time allocated and
the involvement of the midwife.
Leaﬂets can provide a consistent quality and
quantity of information about expanded
screening to all parents. Whilst the adapted
Newborn blood spot screening for your baby
leaﬂet was considered adequate for decision
making, diﬀering individual information
requirements were evident. More detailed
resources are recommended to enable parents to
choose from a range of further information
available to suit their individual requirements.
Autonomous decision making can be addressed
through a pick-and-mix approach to informa-
tion provision. Parents should be empowered to
choose information relevant to their own deci-
sion-making approach and information pro-
cessing capabilities.11 To prevent deterioration
in the capacity to make an informed decision,
further simpliﬁcation of the language and med-
ical terminology as well as a readability assess-
ment may be appropriate.21 It would be
appropriate to include parents in the design of
the information and its allocation to the stan-
dard leaﬂet or more detailed additional
resources.
Timing of information provision
Screening leaﬂets provided too early in preg-
nancy were not meaningful and often forgotten,
whilst information given soon after birth, or
directly before the heel-prick, also failed to
facilitate an informed decision.30 Information
provision late in pregnancy, for example during
a late antenatal appointment with a verbal
reminder days before the test from the midwife is
considered most appropriate. At this time, the
information is salient, and an acceptable time
period is available to digest it and allow an
informed decision.
Role of the midwife
The preference for midwife involvement was
clear, and midwife contribution to the screening
process could be improved. Trust in and the
relationship with the midwife are key to
encouraging participation and parental satis-
faction with their decision.21 In terms of an
expanded screening programme, midwifery
support is needed to ensure consistency and
quality in the approach to providing informa-
tion, assessing understanding and ensuring and
supporting decision making.
Willingness to participate in the screening
programme
The majority of parents would include their child
in an expanded newborn screening programme.
The distinction between service development and
existing clinical practice within this context
however is unclear. For the parent, the inter-
linked nature may lead to speciﬁc ethical issues,
for example whether the pre-scheduled appoint-
ment with the midwife for routine screening
undermines the option of non-participation in
the expanded screening programme. For mid-
wives, this may give priority to screening, at the
expense of informed consent. Furthermore, the
uptake of routine screening could be aﬀected by
an invitation to take part in expanded screening.
These conﬂicts need further consideration.
Clarity is essential, as is the possibility to opt-out
of expanded screening, whilst committing to
routine screening.
Obtaining consent
In terms of consent, a system of informed dissent
or opting out, in line with current service pro-
vision was seen to be desirable by nearly three
quarters of participants. However, improve-
ments could be made to the existing informed
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dissent ⁄ choice model with the optional nature of
screening being made more transparent. Whilst
a formal signature from the parent to document
consent may lead to reassurance that informa-
tion had been adequately relayed and a decision
consciously made, it was not deemed necessary
by the majority of participants.
Limitations of the research
The mixed methodology employing focus
groups and an online survey was designed to
capture a range of diﬀerent perspectives. The
aim was to establish as broad a picture as pos-
sible, by recruiting both parents and parents-to-
be from diﬀerent ethnic backgrounds. The
recruitment of fathers and parents of children
aﬀected by inherited conditions proved diﬃcult.
The context-speciﬁc nature of the subject matter
results in it being meaningful within a certain
period of life, and as a result, the participants are
typical of those considering the screening deci-
sion, rather than the wider population.
Experiences reported are based upon memory
from a time that the participants themselves
recognized as being diﬃcult. Therefore, recol-
lections about information provision for exam-
ple may be inaccurate. This highlights the
challenge in facilitating eﬀective decision making
during the ﬁrst 5–8 days of a childs life, par-
ticularly for ﬁrst time parents.
Conclusions
It might be argued that service developments
require full written informed consent, irrespec-
tive of their nature and design. However, there
are signiﬁcant disadvantages to adopting this
model in an expansion of newborn screening.25
Ponder et al.36 argue that ethical review needs to
be more ﬂexible in its attitude to the provision of
information and consent processes. Here, con-
sent should not be seen in isolation, but as part
of a process where patients are already con-
senting to have blood taken, and the develop-
mental element just applies to subsequent testing
of that blood. A more ﬂexible approach would
facilitate the evaluation of new tests whilst
ensuring participants are adequately informed of
the risk and beneﬁts associated with the project.
Parents need to be provided with compre-
hensive information about expanded screening
at a time that enables them to constructively use
this information in decision making. The New-
born blood spot screening for your baby leaﬂet
was considered to provide adequate information
to allow parents to make an informed decision.
However, midwives need to have a consistent
role in drawing attention to the leaﬂet and in
providing information based upon parental
needs. More detailed resources should be avail-
able from which parents can pick and mix to
empower autonomous decision making.
Gaining informed consent from parents is
complex and time consuming. However, consent
processes need to be ﬂexible and proportionate
with the project being undertaken and with
participant expectations. Parental views indicate
that a model of informed dissent is adequate for
expanded screening.
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